ongoing

Chirpley Joins NVIDIA Inception

Source Node:
Time Stamp: March 20, 2024 5:50 AM - Modified On: March 20, 2024 - Published By:
Source Cluster:
Republished By Plato

  Chirpley, Amsterdam, March 20th— Chirpley today announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements. Chirpley is the world’s first automated peer-to-peer, all-in-one influencer marketplace specifically focused on nano and micro influencers. Chirpley focused on leveraging AI technologies to provide tailored matchmaking for brands and influencers, ensuring efficiency, fair evaluation, and data-driven approach to maximize the reach of marketing incentives. Chirpley plans to use the resources available through NVIDIA Inception, including utilizing NVIDIA most advanced technology assistance and top-notch expertise in AI

AYA and Blockpass Collaborate to Ensure Compliance and Security in a Green Tech Future

Source Node:
Time Stamp: March 6, 2024 4:41 AM - Modified On: March 6, 2024 - Published By:
Source Cluster:
Republished By Plato

HONG KONG, Mar 6, 2024 - (ACN Newswire) - Blockpass is excited to announce a partnership with AYA, a regulated UAE-based fundraising platform focused on the intersection of blockchain and sustainability. Concerned with facilitating innovative solutions which encourage a greener future, AYA mentors and cultivates projects which combine the borderless, transparent nature of blockchain to further the goal of sustainablility and achieving the SDGs. This partnership will see Blockpass strengthening AYA's compliance procedures and providing: risk assessment and risk classification of onboarding customers, customized forms based on the customer's and

Analyzing Token Sale Models

Source Node:
Time Stamp: February 20, 2024 1:29 PM - Modified On: February 20, 2024 - Published By:
Source Cluster:
Republished By Plato

Note: I mention the names of various projects below only to compare and contrast their token sale mechanisms; this should NOT be taken as an endorsement or criticism of any specific project as a whole. It's entirely possible for any given project to be total trash as a whole and yet still have an awesome token sale model. The last few months have seen an increasing amount of innovation in token sale models. Two years ago, the space was simple: there were capped sales, which sold a fixed number of

BTC Markets launches major cryptocurrency Immutable X (IMX)

Source Node:
Time Stamp: February 12, 2024 4:39 AM - Modified On: February 12, 2024 - Published By:
Source Cluster:
Republished By Plato

MELBOURNE, February 12, 2024 -- BTC Markets, one of Australia’s leading cryptocurrency exchanges, is proud to announce the addition of prominent cryptocurrency, Immutable X (IMX) to their platform, with the trading pair IMX/AUD launched on 7 February. This listing marks a significant expansion of the exchange’s digital currency offerings. Launched in 2018 by Australians James Ferguson, Robbie Ferguson, and Alex Connolly, Immutable X has garnered significant attention and success globally, showcasing a remarkable 455% price growth in 2023 and achieving a market cap exceeding US$2.7 billion. Recognised as a major

The Challenges and Opportunities behind the Convergence of AI and Blockchain.

Source Node:
Time Stamp: February 1, 2024 1:28 PM - Modified On: February 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Over the last decade, the potential overlap between cryptocurrency and artificial intelligence (AI) — two significant technological trends of the last decade. The curiosity stems from a natural inclination to find a connection between these innovative domains. On the surface, the synergy seems apparent: the decentralizing force of cryptocurrency could offset the centralizing tendencies of AI, while AI's complexity could be made more transparent through blockchain technologies, which are adept at data management and verification. However, the conversation often hit a snag when delving into concrete applications, leading to

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

Source Node:
Time Stamp: January 29, 2024 6:55 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Zumo first to launch platform built to meet the tech requirements of the FCA’s new Financial Promotions Regime for Crypto Assets

Source Node:
Time Stamp: October 6, 2023 7:12 AM - Modified On: October 6, 2023 - Published By:
Source Cluster:
Republished By Plato

  The award-winning platform has set a new benchmark in consumer protection and regulatory alignment With some UK operators having to pause activity, Zumo’s financial promotions technical flow is now also available through its B2B API to support unregistered firms with remaining compliant after the 8 October deadline [London/Edinburgh - Friday 29 September 2023] Zumo, the UK-based digital-asset-as-a-service platform, has announced a significant industry milestone as it becomes the first digital asset platform to have integrated tech based requirements of the Financial Conduct Authority’s (FCA’s) new financial promotions regime for

Crypto Oasis Ventures Opens New Venture Studio Office at DIFC Innovation Hub and Signs Memorandum of Understanding (MoU)

Source Node:
Time Stamp: July 19, 2023 5:12 AM - Modified On: July 19, 2023 - Published By:
Source Cluster:
Republished By Plato

Crypto Oasis Ventures has signed an MOU with the DIFC Innovation hub to support with subject matter expertise for the Metaverse and Web3 incubators and build ventures in the DIFC Innovation Hub Crypto Oasis Ventures announces opening of new Venture Studio office in the prestigious DIFC Gate Avenue Dubai, UAE; xx July 2023: Crypto Oasis Ventures the inceptor of the fastest growing Blockchain ecosystem in the world, the Crypto Oasis, has signed a Memorandum of Understanding (MoU) with Dubai International Financial Centre (DIFC), the leading financial hub in Dubai. Under

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating